Publisher of the most cited open-access journals in their fields.
Section RNA probes structural and regulatory aspects of all RNAs, both coding and non-coding, via experimental and computational approaches; and publishes cutting-edge basic, translational, and clinical research findings in RNA biology — in particular, those employing the latest technologies to identify RNA-based diagnostics and therapeutics.
Indexed in: PubMed, PubMed Central, Scopus, Google Scholar, DOAJ, CrossRef, Chemical Abstracts Service (CAS), Science Citation Index Expanded, BIOSIS Citation Index, Biological Abstracts
PMCID: all published articles receive a PMCID
RNA welcomes submissions of the following article types: Book Review, Correction, Data Report, Editorial, General Commentary, Hypothesis & Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Protocols, Review, Specialty Grand Challenge and Technology Report.
All manuscripts must be submitted directly to the section RNA, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Articles published in the section RNA will benefit from the Frontiers impact and tiering system after online publication. Authors of published original research with the highest impact, as judged democratically by the readers, will be invited by the Chief Editor to write a Frontiers Focused Review - a tier-climbing article. This is referred to as "democratic tiering". The author selection is based on article impact analytics of original research published in all Frontiers specialty journals and sections. Focused Reviews are centered on the original discovery, place it into a broader context, and aim to address the wider community across all of Genetics and Molecular Biosciences.